Poston, J. N., Fromm, J. R., Rasmussen, H. A., Shustov, A. R., Libby, E. N., Smith, S. D., . . . Gopal, A. K. (2018). A Pilot Study of Weekly Brentuximab Vedotin in Patients with CD30+ Malignancies Resistant to Brentuximab Vedotin every 3 weeks. Br J Haematol.
Citação norma ChicagoPoston, Jacqueline N., Jonathan R. Fromm, Heather A. Rasmussen, Andrei R. Shustov, Edward N. Libby, Stephen D. Smith, Ted Gooley, and Ajay K. Gopal. "A Pilot Study of Weekly Brentuximab Vedotin in Patients With CD30+ Malignancies Resistant to Brentuximab Vedotin Every 3 Weeks." Br J Haematol 2018.
Citação norma MLAPoston, Jacqueline N., et al. "A Pilot Study of Weekly Brentuximab Vedotin in Patients With CD30+ Malignancies Resistant to Brentuximab Vedotin Every 3 Weeks." Br J Haematol 2018.